Shenyang Xingqi Pharmaceutical Co., Ltd. (300573) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenyang Xingqi Pharmaceutical Co., Ltd.

Why is Shenyang Xingqi Pharmaceutical Co., Ltd. ?

With a growth in Net Profit of 40.39%, the company declared Very Positive results in Mar 25

OPERATING CASH FLOW(Y) Highest at CNY 524.17 MM
ROCE(HY) Highest at 25.82%
NET SALES(Q) At CNY 528.5 MM has Grown at 52.83%

With ROE of 28.64%, it has a very attractive valuation with a 7.09 Price to Book Value

Over the past year, while the stock has generated a return of 9.28%, its profits have risen by 56.6% ; the PEG ratio of the company is 2.2
At the current price, the company has a high dividend yield of 2.4

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Shenyang Xingqi Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shenyang Xingqi Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shenyang Xingqi Pharmaceutical Co., Ltd.

19.09%

-0.86

51.77%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

33.24%

EBIT Growth (5y)

63.33%

EBIT to Interest (avg)

91.89

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

0.92

Tax Ratio

15.39%

Dividend Payout Ratio

55.32%

Pledged Shares

Institutional Holding

ROCE (avg)

25.75%

ROE (avg)

17.53%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.09

EV to EBIT

21.25

EV to EBITDA

17.95

EV to Capital Employed

7.80

EV to Sales

5.63

PEG Ratio

2.19

Dividend Yield

2.40%

ROCE (Latest)

36.69%

ROE (Latest)

28.64%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

31What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 524.17 MM

ROCE(HY)

Highest at 25.82%

NET SALES(Q)

At CNY 528.5 MM has Grown at 52.83%

INTEREST COVERAGE RATIO(Q)

Highest at 10,854.85

RAW MATERIAL COST(Y)

Fallen by -9.27% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 8.31%

PRE-TAX PROFIT(Q)

Highest at CNY 177.53 MM

NET PROFIT(Q)

Highest at CNY 145.9 MM

EPS(Q)

Highest at CNY 0.59

-8What is not working for the Company

INTEREST(HY)

At CNY 3.15 MM has Grown at 156.34%

Here's what is working for Shenyang Xingqi Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 177.53 MM has Grown at 326.19%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 145.9 MM has Grown at 319.86%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 524.17 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

At CNY 528.5 MM has Grown at 52.83%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Interest Coverage Ratio

Highest at 10,854.85

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Pre-Tax Profit

Highest at CNY 177.53 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 145.9 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.59

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Highest at 8.31%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -9.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenyang Xingqi Pharmaceutical Co., Ltd.

Interest

At CNY 3.15 MM has Grown at 156.34%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)